4 Therefore, the use of a GLP-1 receptor agonist (exenatide, liraglutide) can be used as monotherapy or dual therapy in those with an A1C of 6.5% to 7.5%
Bottom Line Injection site reactions are one of the more common experiences when starting a GLP-1, and for most people, they stay mild and resolve on their own within a few days
The medication guided your body while you practiced new habits, and now those habits take the lead
A previous drug blocking the receptor, known as rimonabant, had led to depression, anxiety and even suicidal thoughts, and was thus withdrawn from the market after less than three years
Theres no question the convenience of a pill version could expand access and adoption
Microdosing starts at doses below the lowest commercially available starting dose and is titrated slowly to achieve neuromodulatory and metabolic effects without the full appetite suppression or side effects of standard dosing